ERBB2 c.2698A>C ;(p.T900P)

Variant ID: 17-37881628-A-C

NM_004448.2(ERBB2):c.2698A>C;(p.T900P)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15

Variant appearance in text: ERBB2: 2698A>C; Thr900Pro
PubMed Link: 29945233
Variant Present in the following documents:
  • bty518_supplementary_data_s8.xls, sheet 8
View BVdb publication page



Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Molecular Oncology
Keller, Simone S; Zwingenberger, Gwen G; Ebert, Karolin K; Hasenauer, Jan J; Wasmuth, Jacqueline J; Maier, Dieter D; Haffner, Ivonne I; Schierle, Katrin K; Weirich, Gregor G; Luber, Birgit B
Publication Date: 2018-04

Variant appearance in text: ERBB2: T900P
PubMed Link: 29325228
Variant Present in the following documents:
  • MOL2-12-441-s001.pdf
View BVdb publication page



Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.

Oncotarget
Arienti, Chiara C; Zanoni, Michele M; Pignatta, Sara S; Del Rio, Alberto A; Carloni, Silvia S; Tebaldi, Michela M; Tedaldi, Gianluca G; Tesei, Anna A
Publication Date: 2016-04-05

Variant appearance in text: HER2: T900P
PubMed Link: 26919099
Variant Present in the following documents:
  • Main text
  • oncotarget-07-18424.pdf
View BVdb publication page